DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

IOL Chemicals and Pharmaceuticals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·20 Aug 2026, 11:05 am

Company NSE

IOL Chemicals and Pharmaceuticals Limited has announced that the transcript from its recent institutional investor meeting is now available on the stock exchange. This update provides investors with a detailed record of the discussions held during the conference call, which typically cover the company's recent financial performance, future growth strategies, and operational outlook.

This disclosure is significant for retail investors as it offers transparency into management's perspective on market conditions and business plans. By reviewing the transcript, shareholders can better understand the company's trajectory and assess the confidence of institutional participants in its future prospects.

Investors should pay close attention to the management's commentary on demand trends, cost structures, and any guidance provided for upcoming quarters. Keeping an eye on how the stock reacts to the release of this information will be key to gauging market sentiment towards the company.